25 May 2016

Marland group moves into broker

01/04/08 Robert Tyerman

Former Tory treasurer Lord Marland, Carphone Warehouse co-founder David Ross and others plan to put £5 million into diversified stockbroker WH Ireland.

The powerful consortium, whose other members include investment banker Rupert Lowe, a former chairman of Southampton Leisure and director of the London International Financial Futures Exchange, has already paid £1.7 million at 100p a share for 9.9 per cent of Manchester-based WH Ireland. This move, which could have significant implications for the future of the company, is the first step in a process that the consortium hopes will bring it 26 per cent of an enlarged WH Ireland.

It follows one full takeover offer and another partial bid, both of which the company rejected. Under the purchase agreement, Lowe is to become non-executive chairman of the company, replacing former Conservative minister Sir David Trippier, and the entrepreneurial Marland, a financier and previously a leading light at Lloyd’s insurance broker Jardine Lloyd Thompson, joins the board as a non-executive director.

WH Ireland’s two largest shareholders, chief executive Laurie Beevers and managing director David Youngman, are selling parts of their holdings for £877,341 and £438,670 respectively. Subject to regulatory approval by the end of June, the consortium will buy another £1 million worth of shares, including £372,872 from Beevers, Youngman and associates, and then buy five million new shares at 100p each, taking its stake to 26 per cent.

The declared strategy is to expand WH Ireland, which made a flat £3.8 million last year on turnover up 41 per cent to £42.7 million through diversification, with possible acquisitions, following a recent £300,000 wealth management takeover, and partnerships. Beevers, who helped steer the company into corporate finance for junior resource companies from Australia and elsewhere, hopes the deal will help erase the company's 'provincial image' and enthuses that Marland and Lowe ‘are committed to supporting and developing the diversified strategy we have successfully pursued since our AIM admission in 2000’.

The shares, up 3.5p this morning to 111p and valuing WH Ireland at £18.9 million, are, in fact, 4p below the original AIM admission price, having fallen from 194p last October. Investors will hope the new backing and board members will speed recovery.

Growth Company Investor is the UK’s leading authority on small-cap and AIM companies. You can gain immediate access to all the recent share recommendations with no obligation, with a free 30-day trial. Click here to join today.

Cash Shells 2015

Published in September 2015 this annual research report provides a comprehensive overview of cash shells on the Main Market, AIM and PLUS landscape. Order your copy today

 

Superb investment toolkit for private investors

SharePad is the new web-based service from ShareScope. Easier to use and more powerful. Perfect for tablets, Macs and Windows PC. Covers ALL your investment requirements.

Growth Company Investor: free trial

Since 2008, our share tips outperformed the benchmark by 281%. Take a free trial and get access to our recommendations today. Start free trial now.

Directors' Pay on AIM 2015

The most comprehensive review of AIM directors' pay available, and this year includes a record sample of 1000+ AIM-quoted companies. The full report is available to order for £385 + VAT. Click here for more info

 

Latest small-cap and growth company news

Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.

Popular News

Latest News

Motif Bio and the ticking timebomb 23/05/16

The recently published O'Neill report on antimicrobial resistance shows it to be a ticking timebomb. Resistance to antibiotics raises the prospect of 10 million deaths a year by 2050. This is a big opportunity for AIM listed Motif Bio (AIM: MTFB).      

Make mine a double! 19/05/16

Fevertree Drinks (AIM: FEVR) has been one of the most spectacular new issues on AIM in recent years, rising 412 per cent from the float price in late 2014. Today’s trading update served to emphasise why the shares are doing so well and drove them up another 15 per cent.

Fox Marble might be worth the wait  16/05/16

Fox Marble (AIM: FOX) has raised £2 million through a placing at 10p. The funds will be mainly used to complete its long-delayed marble processing factory in Kosovo. Fox has an exciting story but unfortunately is lagging way behind its original roadmap to profitability.

Business as usual at XL Media  12/05/16

XL Media (AIM: XLM) has announced the result of its strategic review. I hope no one was holding their breath, because the conclusion is to carry on as usual! The good news is that trading is said to have ‘maintained its excellent start to 2016’.

A Quantum of solace 11/05/16

Quantum Pharma (AIM: QP.) committed the cardinal sin of overpromising and under-delivering during its first year on AIM. New products took longer to come through the regulatory process than expected, which caused downgrades and a share price collapse from a high of 172p last June to the current 58p. However results for the financial year which ended in January suggest the company is getting to grips with the problems in its Niche Pharmaceuticals division.

Elecosoft constructs a strategy for growth  09/05/16

Elecosoft (AIM: ELCO) is a specialist software company serving architects and builders. It used to be a much larger business but sold out of its building materials businesses four years ago to focus on its software arm. The challenge now is to generate some revenue growth and move off a sales plateau which has been in place since then.

More News